Email Updates

Search form


End of AIDS

The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. To get there we must:

  • Deliver proven tools for immediate impacts.
  • Demonstrate and roll out new HIV prevention tools.
  • Develop long-term solutions to end the epidemic.

Learn more


  • September 18, 2014
    A new contraceptive option, the SILCS Diaphragm, was approved by the FDA for marketing in the US last week and work is underway to get it to women in low-income countries. This development is key as it relates to some of the major research questions under consideration in HIV prevention for women.
  • September 18, 2014
    Our year-long series continues with this Wednesday's webinar on iPrEx OLE and PrEP with investigator Robert Grant. Register for this and other upcoming webinars--and download any you may have missed.
  • September 12, 2014
    A trial designed to evaluate how different methods of contraception affect HIV risk is under-funded and in jeopardy—as explained in a new editorial published on RH Reality Check.
  • September 9, 2014

    At the International AIDS Conference in Melbourne this July, AVAC Executive Director Mitchell Warren spoke with Fred Schaich of the International Foundation for Alternative Research in AIDS (IFARA) about the new global call—issued by UNAIDS—to end the AIDS epidemic by 2030.

Find Resources

AVAC has an extensive online resource library with hundreds of Reports, Publications, Infographics & more. And it includes powerful search features to find exactly what you’re looking for.

What We Do

AVAC uses education, policy analysis, advocacy, community mobilization and a network of global collaborations to accelerate ethical development and global delivery of biomedical HIV prevention options. Read more

Px Methods

AVAC advocates for a comprehensive response to the epidemic, involving smart use of every proven HIV prevention option available today and sustained research into many new strategies.